Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maralixibat in Biliary Atresia Post-Kasai (EMBARK)
NCT04524390Phase 2Completed
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Jul 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of maralixibat in biliary atresia, sponsored by Mirum Pharmaceuticals, Inc.. Started Jul 2021; status: completed.
02
Drugs
maralixibat
03
Conditions
biliary atresia
Beyond the preview
Go deeper on NCT04524390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04524390.